Supplemental material
OncoImmunology
Volume 5, 2016 - Issue 5
Open access
3,605
Views
112
CrossRef citations to date
0
Altmetric
Original Research
Phase II study of the GPC3-derived peptide vaccine as an adjuvant therapy for hepatocellular carcinoma patients
Yu SawadaDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan;Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan
, Toshiaki YoshikawaDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan
, Kazuya OfujiDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan
, Mayuko YoshimuraDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan
, Nobuhiro TsuchiyaDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan;Department of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan
, Mari TakahashiDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan
, Daisuke NobuokaDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan;Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Kita-ku, Okayama, Japan
, Naoto GotohdaDivision of Surgery, National Cancer Center, Hospital East, Kashiwa, Chiba, Japan
, Shinichiro TakahashiDivision of Surgery, National Cancer Center, Hospital East, Kashiwa, Chiba, Japan
, Yuichiro KatoDivision of Surgery, National Cancer Center, Hospital East, Kashiwa, Chiba, Japan
, Masaru KonishiDivision of Surgery, National Cancer Center, Hospital East, Kashiwa, Chiba, Japan
, Taira KinoshitaAichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan
, Masafumi IkedaDivision of Hepatobiliary & Pancreatic Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
, Kohei NakachiDivision of Hepatobiliary & Pancreatic Medical Oncology, National Cancer Center Hospital East, Kashiwa, Chiba, Japan
, Naoya YamazakiDepartment of Dermatology, National Cancer Center Hospital, Chuo-ku, Tokyo, Japan
, Shoichi MizunoDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, Japan
, Tadatoshi TakayamaDepartment of Digestive Surgery, Nihon University School of Medicine, Itabashi-ku, Tokyo, Japan
, Kenji YamaoDepartment of Gastroenterology, Aichi Cancer Center Hospital, Chikusa-ku, Nagoya, Japan
, Katsuhiko UesakaDivision of Hepato-Biliary-Pancreatic Surgery, Shizuoka Cancer Center Hospital, Sunto- Nagaizumi, Shizuoka, Japan
, Junji FuruseDepartment of Medical Oncology, Kyorin University School of Medicine, Mitaka-shi, Tokyo, Japan
, Itaru EndoDepartment of Gastroenterological Surgery, Yokohama City University Graduate School of Medicine, Kanazawa-ku, Yokohama, Japan
& Tetsuya NakatsuraDivision of Cancer Immunotherapy, Exploratory Oncology Research and Clinical Trial Center, National Cancer Center, Kashiwa, Chiba, JapanCorrespondence[email protected]
show all
Article: e1129483
|
Received 28 Oct 2015, Accepted 30 Nov 2015, Published online: 31 May 2016
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.